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Key Messages
• We investigated the subcellular localization of pan-neuronal marker HuC/D in mouse myenteric neurons in
different conditions.
• Immunohistochemical techniques were used to label HuC/D and glial fibrillary acidic protein (GFAP)
expression in the myenteric plexus of the mouse colon.
• Hypoxia-induced damage results in a predominantly nuclear localization of HuC/D.
• Nuclear HuC/D localization was associated with the activation of a non-apoptotic genetic program and
distortion of the glial network.
• HuC/D protein is more than a pan-neuronal marker as its subcellular localization reflects the health status of
the neurons.
Abstract
Background Correct neuronal identification is essen-
tial to study neurons in health and disease. Although
commonly used as pan-neuronal marker, HuC/D’s
expression pattern varies substantially between
healthy and (patho)physiological conditions. This
heterogenic labeling has received very little attention.
We sought to investigate the subcellular HuC/D
localization in enteric neurons in different conditions.
Methods The localization of neuronal RNA-binding
proteins HuC/D was investigated by immunohisto-
chemistry in the mouse myenteric plexus using
different toxins and caustic agents. Preparations were
also stained with Sox10 and glial fibrillary acidic
protein (GFAP) antibodies to assess enteric glial cell
appearance. Key Results Mechanically induced tissue
damage, interference with the respiratory chain and
oxygen (O2) deprivation increased nuclear HuC/D
immunoreactivity. This effect was paralleled by a
distortion of the GFAP-labeled glial network along
with a loss of Sox10 expression and coincided with the
activation of a non-apoptotic genetic program. Chem-
ically induced damage and specific noxious stimuli
did not induce a change in HuC/D immunoreactivity,
supporting the specific nature of the nuclear HuC/D
localization. Conclusions & Inferences HuC/D is not
merely a pan-neuronal marker but its subcellular
localization also reflects the condition of a neuron at
the time of fixation. The functional meaning of this
change in HuC/D localization is not entirely clear,
but disturbance in O2 supply in combination with
the support of enteric glial cells seems to play a
crucial role. The molecular consequence of
changes in HuC/D expression needs to be further
investigated.
Keywords enteric neurons, GFAP, glial cells, HuC/D,
hypoxia.
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INTRODUCTION
Correct identification of neurons is critical to investi-
gate and understand morphological and functional
changes that may occur during health and disease.
HuC/D protein is routinely used as neuronal marker
both in the central and in the peripheral nervous
system. HuC/D is not only neuron-specific, but it also
labels all neurons rather than specific subpopulations;
hence the adjective ‘pan-neuronal’ marker.1–3 Another
practical advantage of the HuC/D staining is that
quantification of individual neurons is made easy, as
unlike other commonly used neuronal markers (PGP
9.5, peripherin and neurofilament), it does not label
neuronal processes.1 HuC/D belongs to the family of
Hu proteins, the human homologs of Drosophila Mel-
anogaster Embryonic Lethal Abnormal Vision (ELAV)
proteins.4 Hu proteins were first discovered as autoan-
tibodies in the circulation of patients with paraneo-
plastic encephalomyelitis (Hu syndrome), who aside
from their neuro-immune problems also suffer from
gastrointestinal problems.5–7 Functionally, HuC/D,
and Hu proteins in general, regulates the stability of
specific mRNA and thereby modulate and control the
precise temporal expression of certain proteins.8,9
Moreover, Hu proteins also regulate mRNA localiza-
tion andmicroRNA-mediated repression.10 Hu proteins
can bind specific mRNA (e.g., VEGF, AChE, BDNF,
GAP43)11–16 through particular recognition motifs that
interact with adenine uridine-rich elements in the 30
untranslated region. Because of this role in mRNA
stabilization, HuC/D normally resides in the cytosol,
but it can also be present in the nucleus where specific
transporter proteins that shuttle Hu proteins through
the nuclear envelope have been described.17 Although
its role in the nucleus is still elusive, HuC/D has been
suggested to be involved in regulation of polyadenyla-
tion and alternative splicing.10
The heterogeneity with respect to expression levels
in different subcellular compartments, which is appar-
ent in many published micrographs10,18–20 is not
restricted to the enteric nervous system (ENS), but is
also present in the central nervous system. Strangely,
this heterogeneity has been largely ignored, except for
some intestinal ischemia-reperfusion studies, where
nuclear expression of Hu proteins, associated with
elevated nitrosylation levels,21,22 was reported. The
underlying reasons for this change in subcellular
localization are still unknown, but the HuC/D expres-
sion pattern may reflect a condition of neuronal stress
and damage, during which altered regulation of mRNA
or alternative splicing is needed. A dedicated study of
HuC/D expression patterns is thus warranted to
understand what extra information HuC/D labeling
might yield about neuronal health.
Therefore, the aim of this study was to gain insight
in the mechanisms underlying different HuC/D
expression patterns in ENS neurons. We used myen-
teric plexus preparations from mouse colon and mim-
icked neuronal damage in vitro. As it is well
established that enteric neurons are tightly packed
and interact with glial cells within the ENS, we also
evaluated the expression of typical glial markers to
investigate whether glial abnormalities would parallel
or correspond to the altered HuC/D expression.
We found that oxygen (O2) deprivation is an impor-
tant trigger to alter intracellular localization of HuC/D
in enteric neurons. Under low oxygen conditions, an
increased nuclear HuC/D immunoreactivity was
found, a phenomenon that was associated with severe
abnormalities in the enteric glial network.
MATERIALS AND METHODS
Animals and tissue preparation
C57BL/6 mice with ad libitum access to standard chow (Sniff;
Soest, Germany) and tap water were used in this study. They were
sacrificed by cervical dislocation as approved by the animal Ethics
Committee of the University of Leuven, Belgium.
The colon was removed and put in Krebs solution (120.9 mM
NaCl [Normapur VWR, Singapore, Singapore], 5.9 mM KCl
[Normapur VWR], 1.2 mM MgCl2 [Normapur VWR], 11.5 mM
glucose [Merck, Darmstadt, Germany], 14.4 mM NaHCO3
[Merck], 1.2 mM NaH2PO4, and 2.5 mM CaCl2 [Merck]) oxy-
genated with 95% O2/5% carbon dioxide (CO2). The mid and
distal colon was cleared from fat, cut along the mesenteric
border and pinned flat in a Sylgard Petri dish. The mucosa and
submucosal layers and longitudinal muscle layers were then
removed to obtain myenteric plexus preparations. Tissue incu-
bations were performed in small glass dishes (diameter: 3 cm)
containing a Sylgard layer. The dissected myenteric plexus was
pinned and lifted from the bottom to allow sufficient circula-
tion of nutrients, buffer, and O2 in the entire dish.
Different experimental conditions were designed to
induce changes in subcellular HuC/D localization. We applied
(i) mechanically induced tissue damage, (ii) chemically induced tis-
sue damage, (iii) endoplasmic-reticulum (ER) stress-induced dam-
age, (iv) pro-inflammatory cytokines-induced damage, (v) specific
inhibition of the respiratory chain, (vi) O2 deprivation, and (vii)
toxin-induced glial damage (see Table 1).
In a first set of experiments, the myenteric plexus was kept in
oxygenated Krebs solution at room temperature (RT) 1, 2, or 4 h
before fixation to test whether dissection-induced tissue damage
would cause changes in HuC/D localization. Mechanical damage
was induced by gently scratching (0.5 mm) the tissue using a
blunt surgical blade in the middle of a 1 cm2 myenteric plexus
preparation (Table 1). Chemical damage was induced by incubat-
ing the myenteric plexus in Krebs solution containing 0.1%
Benzalkoniumchloride (BACl, 1 h). O2 deprivation, to mimic
ischemic conditions, was induced by continuous bubbling with
100% N2 (1–2 h: pH 9), while pH effects were tested in Krebs (pH:
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6.45–8.1) bubbled with O2 instead of carbogen gas (1–2 h of
incubation; Table 1). In a last set of experiments, tissues were
incubated for 2 h in Krebs buffer containing high concentrations
(5%) of Triton X-100 (Table 1).
For longer incubations we used a complete medium DMEM/
F12 1:1 (Gibco; Invitrogen, Merelbeke, Belgium) enriched with
2 mM L-glutamine + 50 U/mL Penicillin + 50 U/mL Streptomy-
cin + 10% fetal bovine serum (all from Lonza, Group Ltd, Basel,
Switzerland) and placed the myenteric plexus in an incubator at
37 °C (5% CO2/95% air). ER stress was induced by thapsigargin
(100 nM), while an inflammatory condition was modeled by
adding a mixture of 10 ng/mL tumor necrosis factor-alpha (TNF-a)
+ 10 ng/mL interleukin-1beta (IL-1b) to the culture medium
(Table 1). Rotenone (100 nM) was used to specifically interfere
with the electron transport chain in mitochondria (Table 1). Glial
damage was induced by incubating the plexus in complete
medium containing 10 lM fluorocitrate (Table 1).
At the end of each experimental condition, tissues were fixed
for 45 min at RT in 4% paraformaldehyde (Sigma-Aldrich,
Bornem, Belgium) diluted in 0.2 M PBS (29.6 mM NaH2PO4
[Merck], 184.7 mM Na2HPO4 [Normapur VWR], pH 8) and then
thoroughly washed in 0.1 M PBS (1.54 mM KH2PO4 [Merck],
155.17 mM NaCl [Normapur VWR], 2.71 mM Na2HPO4 [Norma-
pur VWR]).
Immunohistochemistry
Tissues were incubated for 2 h (overnight for c-Fos immunostain-
ing) at RT in blocking solution containing 0.5% Triton X-100
diluted in 0.1 M PBS and 4% serum of the secondary antibody
hosts followed by incubation overnight at 4 °C with the primary
antibodies diluted in blocking medium (Table 2). After washing in
PBS, the tissues were incubated for 2 h at RT with appropriate
secondary antibodies (Table 2) diluted in blocking buffer. After
washing in PBS, tissues were mounted on a microscope slide in
citifluor (Citifluor Ltd., Leicester, UK). To assure that the nuclear
envelope was sufficiently permeable, we also performed an
immunohistochemical labeling in solutions containing 5% Tri-
ton X-100 instead of 0.5%.
The Invitrogen antibody was used for all HuC/D stainings,
which were double-checked for specificity in a select set of
experiments (data not shown), using a human anti-Hu antibody
(Source: Lennon7).
TUNEL assay
After immunohistochemistry, aTUNELassaywas performedusing
an in situ cell death detection kit (Roche Applied Science, Vilvo-
orde, Belgium). After washing in PBS, tissues were incubated for
2 min on ice in permeabilization solution containing 0.1% Triton
X-100 and 0.1% sodium citrate. The samples were then washed in
PBS and the TUNEL reactionmixture was added to the samples for
1 h at 37 °C in humid environment. Afterward, the tissues
were washed in 0.1 M PBS and mounted on a microscope slide.
Drugs and materials
Rotenone, thapsigargin, IL-1b, and fluorocitrate were from Sigma-
Aldrich, while TNF-a was from Invitrogen. Benzalkoniumchlo-
ride was kindly provided by Prof. Herman Van Pee (Faculty of
Pharmaceutical Sciences, University of Leuven).
Table 1 Specification of different incubation conditions
Experiment Treatment Incubation conditions
Mild damage Time (after dissection) Krebs buffer (RT, 1–4 h)
Mechanical damage Nerve crushing using blunt surgical blade Krebs buffer (RT, up to 2 h)
Chemically induced damage 0.1% Benzalkoniumchloride (BACl) Krebs buffer (RT, up to 2 h)
Oxygen deprivation (hypoxia) Bubbled with 100% N2 Krebs buffer (RT, up to 2 h)
pH effect pH 6.45 bubbled with 100% O2
pH 8.1 bubbled with 100% O2
Krebs buffer (RT, up to 2 h)
Triton X-100 5% Triton X-100
ER stress-induced damage 100 nM thapsigargin Complete medium (37 °C, 3–24 h)
Pro-inflammatory cytokines 10 ng/mL TNF-a + 10 ng/mL IL-1b Complete medium (37 °C, 3–24 h)
Mitochondrial complex I inhibition 100 nM rotenone Complete medium (37 °C, 3–24 h)
Toxin-induced glial damage 10 lM fluorocitrate Complete medium (37 °C, 3–24 h)
Table 2 Specification of antibodies, with dilution, host, and source
Antigen Host Dilution Source
HuC/D Mouse 1/500 Invitrogen Life Technologies, Ghent, Belgium
GFAP Chicken 1/5000 Abcam, Cambridge, UK
Sox10 Goat 1/300 Santa Cruz Biotechnologies, Santa Cruz, CA, USA
c-Fos Rabbit 1/500 Santa Cruz Biotechnologies
Hu Human 1/5000 Lennon7
Mouse-IgG Alexa 488 Donkey 1/1000 Molecular Probes, Leiden, The Netherlands
Mouse-IgG Alexa 594 Donkey 1/1000 Molecular Probes
Chicken-IgG Alexa 594 Goat 1/1000 Molecular Probes
Goat-IgG Alexa 594 Donkey 1/1000 Molecular Probes
Rabbit-IgG Alexa 594 Donkey 1/1000 Molecular Probes
Human-IgG FITC Goat 1/250 Jackson Immuno Labs, West grove, PA, USA
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Data presentation and statistical analysis
Immunohistochemical stainings were visualized under an epiflu-
orescence microscope (BX41 Olympus, Aartselaar, Belgium) with
specific filter cubes (Ex/DM/Em in nm: 325–375/400/435–485;
460–495/505/510–550; 570–590/595/600–660) for respectively
blue, green, and red probes. An XM10 (Olympus) camera using
Cell^F software was used to record the images. Before overlay,
pictures were adjusted for contrast and brightness. Three ganglia
per tissue were analyzed for each experimental condition in five
independent experiments. Exposure times were kept constant to
assure a correct comparison between different experiments. The
intensity ofHuC/D stainingwas then calculated in the nucleus and
cytosol of each neuron (Cell^F software) to calculate the expression
ratio, which will be referred to as the HuC/D intensity ratio
throughout themanuscript. The statistical analysis was performed
with Graphpad prism software. As data were not normally distrib-
uted (D’Agostino & Pearson omnibus normality test), non-para-
metric Mann–Whitney U and Kruskal–Wallis followed by Dunns
post hoc tests were used to compare different conditions. The data
are presented by mean  SEM. Differences were considered to be
significant if the p value was smaller than 0.05.
RESULTS
HuC/D labeling shows substantial heterogeneity
in its subcellular localization
Immunohistochemical labeling reveals thatHuC/D can
be expressed at different levels in the cytosol and in the
nucleus of neurons (Fig. 1A). In a first set of experi-
ments, during which tissues were kept in oxygenated
Krebs buffer at RT before fixation, we found that the
presence of HuC/D in the nucleus increased as incuba-
tion time progressed (time 0: 5.4  1.01 vs 2 h: 21.4 
3.4%; **p < 0.01, 1 h: 9.5  2.3% vs 4 h: 39.6  3.6%;
***p < 0.001, time 0 vs 4 h; ***p < 0.001; Fig. 1C, left).
In addition, we found that the number of neurons per
ganglion was not significantly different after different
periods of incubation (Fig. 1C, right). In addition, we
found that this was associated with alterations of the
A
B
C
Figure 1 Heterogeneous expression and
localization of the neuronal marker HuC/D
in myenteric neurons. (A, top left) Confocal
images of a neuron stained with an antibody
against HuC/D: note the fairly
homogeneous staining in the cytosol,
counterstained with DAPI (A, top middle),
and merged image (A, top right). (A, bottom
left) Confocal images of a neuron stained
with an antibody against HuC/D, DAPI
counterstaining (A, bottom middle), and
merged image (A, bottom right). Note the
brighter staining in the nucleus; scale bars:
5 lm. (B) Representative
immunohistochemical staining (HuC/D and
glial marker GFAP) of a tissue that was fixed
immediately (time 0, top) or 4 h (bottom)
after dissection. Note the intense nuclear
HuC/D staining (arrows, left) and disrupted
GFAP staining (arrows, middle). Merged
image in B, right; scale bars: 100 lm.
(C) Graphs showing the number of neurons
with nuclear HuC/D compared to the total
number of neurons (in %, per ganglion) in
tissues fixed at different time points after
dissection (**p < 0.01, ***p < 0.001; left)
and the total number of neurons/ganglion
(p > 0.05; right).
© 2014 John Wiley & Sons Ltd4
A.-S. Desmet et al. Neurogastroenterology and Motility
enteric glial network as shownby a loss and distortion of
GFAP expression (Fig. 1B). We hypothesize that the
tissue damage induced by dissection progressively
affects neurons and enteric glial cells during RT incu-
bation. To further characterize the nature of the specific
subcellular HuC/D localization, we performed different
sets of in vitro experiments ranging from mechanical
damage and toxin exposure to significant pH changes
and O2 deprivation.
Mechanical damage induces changes in HuC/D
expression in myenteric neurons
To test whether mechanical damage (to mimic nerve
crushing) could affect the intracellular localization of
the HuC/D protein, we made a scratch using a blunt
surgical blade in the middle of a square cm myenteric
plexus preparation (Fig. 2A). After 2 h at RT, we found
that the HuC/D staining was more prominent in the
nucleus compared to the control condition (HuC/D
intensity ratio: 2.0  0.14 vs 1.2  0.06; ***p < 0.001;
Fig. 2C, left). Interestingly, this increase was only
found in the damaged region (2.0  0.14 vs
0.9  0.03; ***p < 0.001; Fig. 2C, left), indicating that
the damage did not progressively affect other areas.
Here, enteric glial network distortion and fragmented
GFAP pattern were also visible in close proximity to
the mechanical damage (Fig. 2A).
BACl does not affect HuC/D expression in
myenteric neurons
We sought to produce damage over a larger area by
incubating the tissue in the presence of BACl, a
cationic surfactant used to damage and kill myenteric
neurons.23–25 We found no additive effect of 0.1% BACl
(1 h) on the HuC/D intensity ratio compared to control
(1.6  0.06 vs 1.5  0.08; p > 0.05; Fig. 2C, right). The
enteric glial network was weakly affected but only in
specific regions (Fig. 2B).
Effect of pathological and noxious stimuli on
HuC/D expression in myenteric neurons
As the nuclear HuC/D expression was more intense
when cellular damage was elicited in vitro, we also
tested whether other noxious stimuli, as used in
disease models, had similar effects. During tissue
incubation, the number of HuC/D positive neurons
remained constant and comparable to directly fixed
A
B
C
Figure 2 Mechanical damage causes
changes in HuC/D expression in myenteric
neurons. (A) Representative
immunostaining of the myenteric plexus in
a tissue that was gently scratched (in
between the dashed lines). Left: HuC/D
expression is more intense in the nucleus at
the location of the scratch (enlarged picture,
left insets) compared to regions adjacent to
the scratch (enlarged picture, right insets).
Middle: Changes in HuC/D staining were
associated with distorted GFAP expression.
Merged images in A, right. (A, bottom row)
Enlarged images of the scratch (left) and
adjacent to scratch (right); scale bars:
200 lm in the top, 100 lm in the bottom
row. (B) Representative immunostaining of a
myenteric ganglion exposed to 0.1% BACl.
Left: HuC/D expression is homogeneous in
the neuronal cell body.Middle: BACl caused
distortion of GFAP expression. Merged
image in B, right; scale bars: 100 lm.
(C) Graphs showing the mean HuC/D
intensity ratio between nucleus/cytosol
after mechanical damage (left; ***p < 0.001)
and after application of cationic surfactant
BACl (right; p > 0.05).
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tissue (dashed line Fig. 3, right), with the sole excep-
tion of a small reduction at 24 h.
Thapsigargin-induced ER stress. Thapsigargin is
known to act as an ER stressor as it inhibits the
SERCA pump, resulting in Ca2+ depletion of the
ER.26,27 We used thapsigargin (100 nM) to investigate
whether ER stress, and the consecutive unfolded
protein response pathway, would induce changes in
HuC/D expression, but we found no differences in the
HuC/D intensity ratio between control and treated
condition (all p > 0.05; Fig. 3A, left).
Pro-inflammatory mediators (TNF-a + IL-1b). As
inflammation plays a crucial role in many gastrointes-
tinal disorders, myenteric plexus preparations were
exposed to a mixture of pro-inflammatory cytokines
TNF-a and IL-1b.28 Again, no significant differences
were found in the HuC/D intensity ratio between
control and treated condition (all p > 0.05; Fig. 3B, left).
Blockade of the respiratory chain results in HuC/
D expression changes
We used the environmental toxin rotenone, a well-
known blocker of mitochondrial complex 129,30 to
interfere with the respiratory chain. The HuC/D
intensity ratio was significantly higher in treated
(3–6 h) compared to control conditions (ctrl 3 h:
1.03  0.03 vs rotenone 3 h: 1.17  0.06; *p < 0.05,
ctrl 6 h: 1.01  0.02 vs rotenone 6 h: 1.27  0.03;
**p < 0.01), while this increase vanished after longer
incubation (Fig. 4B, left). We also found that the
number of HuC/D-positive neurons per ganglion
decreased the longer the tissue was incubated (ctrl
6 h: 39.96  3.4 vs ctrl 24 h: 26.43  2.7; *p < 0.05,
rotenone 3 h: 46.25  4.0 vs rotenone 24 h:
21.67  3.2; ***p < 0.001, rotenone 6 h: 47.50  4.5
vs rotenone 24 h; ***p < 0.001; Fig. 4B, right; direct:
34.5  2.4 vs control 24 h: 26.43  2.7; *p < 0.05,
direct vs rotenone 24 h: 21.67  3.2; **p < 0.01;
Fig. 4B, right). Similar to other conditions, we also
found the GFAP expression pattern distorted after
rotenone application (Fig. 4A).
Hypoxia but not pH induces an increase in
nuclear HuC/D immunoreactivity
During the experiments in which tissues were
mechanically damaged, the question arose as to
whether it was shortage of O2 that could be responsible
for the change in HuC/D localization. We tested the
effect of hypoxia by bubbling with N2 to deplete O2
(Fig. 5A).31,32 We found that the HuC/D intensity ratio
was significantly increased compared to control both
after 1 h (1.0  0.03 vs 1.4  0.07; ***p < 0.001) and
2 h (1.4  0.07 vs 1.8  0.08; ***p < 0.001) incubation
at RT (Fig. 5B, left). In the vicinity of neurons with
predominant nuclear HuC/D expression, the GFAP
pattern was also fragmented and completely different
from a normal GFAP expression pattern (Fig. 5A).
To exclude that the increased HuC/D intensity ratio
under hypoxic conditions was due to pH changes, we
incubated tissues at different pH. We found that
neither an increase (pH 8.1) nor a decrease (pH 6.4) in
pH had an effect on the HuC/D intensity ratio (ctrl 2 h:
1.2  0.06 vs pH 6: 1.1  0.1 vs pH 8: 1.0  0.1;
p > 0.05; data not shown).
A
B
Figure 3 Effect of ER stress and pro-
inflammatory cytokines on HuC/D
expression in myenteric neurons. (A) Graphs
showing the mean HuC/D intensity ratio
nucleus/cytosol (no significant differences
were found; p > 0.05; left) and the total
number of HuC/D-positive neurons/
ganglion (right) after incubation with the ER
stress inducer, thapsigargin, at different
time points. (B) Graphs showing the mean
HuC/D intensity ratio nucleus/cytosol (no
significant differences were found; p > 0.05;
left) and the total number of HuC/D-positive
neurons/ganglion (right) after incubation
with a mixture of pro-inflammatory
cytokines, TNFa + IL-1b, at different time
points. The dashed line in (A) and (B)
represents the average number of HuC/D-
positive neurons per ganglion in tissues that
were immediately fixed (34.5  2.4).
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Enteric glial network distortion parallels nuclear
HuC/D expression in neurons
As glial cells in the gut are known to play an
important supportive role for neurons in the
ENS,33,34 we analyzed the enteric glial network using
GFAP staining after each experimental condition. We
found that when HuC/D expression was predominant
in the nucleus, there was a parallel distortion of the
GFAP pattern. In addition, Sox10 immunoreactivity
was not detectable in the vicinity of myenteric
neurons with high HuC/D intensity ratios (Fig. 6A),
A
B
Figure 4 Inhibition of the respiratory chain
changes the HuC/D expression in myenteric
neurons. (A) Representative
immunohistochemical staining of the
neuronal marker HuC/D (left) and glial
marker GFAP (middle) after 3 h (top) and
6 h (bottom) rotenone (100 nM) incubation.
Note the intense nuclear HuC/D staining
(arrows, left) and the distortion of GFAP
staining (arrows, middle). Merged images in
A, right; scale bars: 100 lm. (B) Graphs
showing the effect of rotenone after 3 and
6 h incubation on the mean HuC/D
intensity ratio nucleus/cytosol (left;
*p < 0.05, **p < 0.01 vs ctrl) and the
number of HuC/D-positive neurons/
ganglion (right; ctrl 24 h vs direct; *p < 0.05,
rotenone 24 h vs direct; **p < 0.01 and
effect over time *p < 0.05, ***p < 0.001).
The dashed line shows the average number
of neurons per ganglion in a directly fixed
tissue (34.5  2.4).
A
B
Figure 5 Hypoxia but not altered pH
changes in HuC/D expression in myenteric
neurons. (A) Representative
immunohistochemical staining of HuC/D
(left) and GFAP (middle) in a myenteric
ganglion after incubation in hypoxic
conditions (1 h up, 2 h bottom). Note the
intense nuclear HuC/D staining (arrows,
left) and the distorted GFAP staining
(arrows, middle). Merged images in A, right;
scale bars: 100 lm. (B) Graphs showing the
effect of hypoxia (1 and 2 h) on the mean
HuC/D intensity ratio nucleus/cytosol
(***p < 0.001 vs normoxia (left) and the
total number of HuC/D-positive neurons/
ganglion (right)).
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which again suggests that enteric glial cells are
affected by the same type of interventions that cause
nuclear HuC/D expression.
Fluorocitrate results in a dominant nuclear HuC/D
immunoreactivity. To further investigate whether
enteric glial cells play an active role in the localization
of HuC/D, we used fluorocitrate (10 lM), a toxin
reported to interfere with enteric glial metabolism.35,36
Although not different for shorter incubations, we
measured a significant increase in HuC/D intensity
ratio after 24-h fluorocitrate incubation (ctrl:
1.02  0.04 vs fluorocitrate: 1.17  0.04; *p < 0.05;
Fig. 6C, left). We also found that fluorocitrate wors-
ened the loss of HuC/D-positive neurons after 24-h
incubation compared to tissues that were directly fixed
(direct: 34.5  2.4 vs control 24 h: 26.4  2.7;
*p < 0.05, direct vs fluorocitrate 24 h: 21.7  2.0;
***p < 0.001; Fig. 6C, right). Contrary to the other
toxin conditions, where we found distortion of the
enteric glial network (fragmentation of the GFAP
pattern), fluorocitrate enhanced the GFAP expression
making it reminiscent of reactive gliosis (Fig. 6B).
Nuclear HuC/D immunoreactivity is associated
with a non-apoptotic genetic program
As it is not entirely clear why HuC/D is more
predominant in the nucleus, we tested whether this
event coincided with the activation of gene transcrip-
tion. We used an antibody against the early gene
product c-Fos and found a clear increase in neurons
with nuclear HuC/D, while neurons with mainly
cytosolic expression did not show c-Fos labeling
(Fig. 7A, top). We also found that extreme and harsh
damage (5% Triton X-100) to the tissue resulted in a
bright nuclear HuC/D together with a positive c-Fos
staining in all neurons (Fig. 7A, bottom). We also used
TUNEL staining to assess the involvement of apopto-
tic pathways, but as shown in Fig. 7B, none of the
neurons with nuclear HuC/D staining displayed signs
of apoptosis.
A
B
C
Figure 6 Enteric glial network distortion
parallels the changes in HuC/D expression.
(A) Representative immunohistochemical
staining of neuronal marker HuC/D (left)
and glial marker Sox10 (middle) in control
conditions (up) and with nuclear
localization of HuC/D (bottom). Note that
when HuC/D staining is more intense in the
nucleus of myenteric neurons, Sox10
immunoreactivity is not detectable. Merged
image in A, right; scale bars: 100 lm. (B)
Representative immunohistochemical
staining of the neuronal marker HuC/D
(left) and the glial marker GFAP (middle)
after incubation for 24 h with gliotoxin
fluorocitrate. Note the signs of GFAP
overexpression (reminiscent of reactive
gliosis; arrows, middle) and nuclear
occurrence of HuC/D in neurons in the
vicinity (arrows, left). Merged images in B,
right; scale bars: 100 lm. (C) Graphs
showing the effect of fluorocitrate
incubation over time on the mean HuC/D
intensity ratio nucleus/cytosol (fluorocitrate
24 h vs ctrl 24 h; *p < 0.05, left) and the
total number of HuC/D-positive neurons/
ganglion (right; ctrl 24 h vs direct; *p < 0.05,
fluorocitrate 24 h vs direct; ***p < 0.001).
The dashed line shows the average number
of neurons in a directly fixed tissue
(34.5  2.4).
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Permeability of the nuclear envelope is not
involved in HuC/D localization change
To investigate whether damage to the nuclear enve-
lope, which at the time of immunostaining would
allow antibodies to penetrate more easily into the
nucleus, could explain enhanced nuclear HuC/D label-
ing, we performed immunostainings in high concen-
trations of Triton X-100 (5%) assuring full envelope
permeabilization. We found no evidence for brighter
nuclear staining (Fig. 8) in directly fixed tissues, which
prove that antibody penetration into the nucleus is not
an issue.
DISCUSSION
The use of adequate neuronal markers is crucial for
the identification and characterization of neurons
both in the central and in the peripheral nervous
system. The specific pan-neuronal protein HuC/D is
commonly used, as it allows correct quantification of
neuronal cell bodies1–3 mainly because the HuC/D
antibody does not label neuronal processes. However,
the widespread use of HuC/D has also revealed a
remarkable heterogeneity in expression levels and
subcellular localization of the protein, especially
with respect to cytosolic or nuclear appearance. This
A
B
Figure 7 Nuclear localization of HuC/D coincides with the initiation of a non-apoptotic genetic program. (A, top row) Representative
immunohistochemical staining of the neuronal marker HuC/D (right) in combination with the early gene c-Fos as marker for neuronal activity
(middle) in a tissue kept 2 h in hypoxic conditions. Merged image in A, right. Arrows indicate neurons that display cytosolic staining for HuC/D, and
have negative c-Fos nuclei. Nuclear HuC/D-stained neurons and c-Fos-positive neurons are marked by an arrowhead; scale bars: 100 lm. (A, bottom
row) Representative image of the myenteric plexus incubated for 2 h in Krebs containing 5% Triton X-100. Note the intense nuclear HuC/D staining
(left) in combination with a positive c-Fos staining (middle). Merged image in B, right; scale bars: 100 lm. Note that this exemplifies the most
extreme case of nuclear HuC/D. (B) TUNEL staining of a representative myenteric ganglion in tissue that was mechanically damaged (scratch). HuC/
D is mainly present in the nucleus (left, arrowheads), while no signs of apoptosis (TUNEL) can be detected (middle, arrowheads). Note that some
muscle cells have TUNEL-positive nuclei. Merged image in B, right; scale bars: 100 lm.
Figure 8 Permeability of the nuclear envelope is not involved in HuC/D localization change. Representative images of an immunohistochemical
staining performed with blocking medium containing 5% Triton X-100 on a directly fixed myenteric plexus preparation. The HuC/D protein is
present in the cytosol (left) and no typical nuclear staining is revealed. Note that as in other control tissues that were fixed directly, there were hardly
any c-Fos-labeled (middle) neurons. Merged image in 8, right; scale bars: 100 lm.
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heterogenic expression pattern, present both in cen-
tral and peripheral neurons, remains poorly under-
stood. It has been used as a read-out for enteric
damage but without addressing the underlying mech-
anism.22 Therefore, we decided, using in vitro exper-
iments, to identify the (pathological) conditions that
induce changes in HuC/D localization in enteric
neurons.
Firstly, we show that time-controlled incubation in
simple Krebs buffer induced changes in HuC/D expres-
sion patterns in myenteric neurons. With time, pro-
gressively more neurons with nuclear HuC/D labeling
were found, which deviates from the cytosolic expres-
sion under physiological conditions (as per fixation at
time 0). These data demonstrate that it is crucial to
carefully consider time before fixation as an important
parameter during experimental treatment of nerve
tissues. Our findings also indicate that stressful envi-
ronmental conditions affect both neurons and enteric
glial cells, which results in translocation of HuC/D to
the neuronal nucleus, while GFAP expression in
enteric glial cells becomes distorted. The nuclear
localization of HuC/D coincides with the activation
of early gene (c-Fos), but is not necessarily linked to
apoptotic signaling pathways. On the basis of these
findings, we hypothesize that the altered HuC/D
localization, is likely due to an active translocation of
HuC/D to the nucleus, which is necessary to switch on
recovery programs to deal with specific nerve-
damaging conditions.
Several studies have highlighted the fact that
mechanical damage can have serious consequences
for tissue survival and functioning.37 We found that
mechanical damage indeed changed HuC/D expression
toward a dominant nuclear localization, at least in
those ganglia relatively close to the insult. In an
attempt to induce more widespread damage, we applied
the cationic surfactant BACl, known to destroy enteric
neurons.23,24 However, BACl incubation did not
induce any difference in HuC/D expression, which
indicates that the nuclear immunoreactivity is possi-
bly specific to a certain type of damage. On the other
hand, it is possible that the effect of BACl was not fully
developed as it has been shown to require a full
immunological activation which is not present
in vitro.38,39
We further designed in vitro experiments using
different molecules known to induce cellular or tissue
stress. Neither ER stress, induced by thapsigargin, nor
pro-inflammatory stimuli (TNF-a and IL-1b), resulted
in more HuC/D immunoreactivity in the nucleus.
Conversely, rotenone, a drug that blocks the respira-
tory chain by inhibiting mitochondrial complex 1,
induced a significant increase in the nuclear expression
of HuC/D intensity ratio after 3–6 h of incubation.
Intriguingly, we did not find any significant difference
after longer incubation. At the moment, it remains
unclear whether a compensatory mechanism is acti-
vated or whether some neurons recover from the insult
even in the presence of the toxin. These results
indicate that interfering with the electron transport
chain in mitochondria can alter HuC/D expression,
which led us to test the effect of O2 availability and
hypoxia.
A vast amount of literature exists to show that
intestinal ischemia is a significant clinical problem
that leads to structural and functional changes in
enteric neurons and glial cells. A hypoxic situation
due to interruption of the blood supply can cause
impairment of absorption, motility and intestinal
barrier function.40–42 When hypoxia was mimicked in
vitro, we found that HuC/D had indeed accumulated
in the neuronal nucleus. This change in localiza-
tion was specifically due to shortage of O2, as
modification of pH did not cause any significant
change. Our hypoxia experiments confirm the obser-
vations from in vivo ischemia/reperfusion assays,
which resulted in bright nuclear HuC/D expression
in over 35% of enteric neurons.21,22 Together with
the results of the rotenone incubation experiments,
these data demonstrate that lack of respiration is a
trigger for the change in subcellular HuC/D
localization.
Throughout this study, we observed that nuclear
localization of HuC/D was associated with a distortion
of the GFAP expression and even a loss of Sox10
immunoreactivity in enteric glial cells. We, therefore,
tested the effect of glial toxin fluorocitrate, but found
only minimal effects on the localization of HuC/D.
Although it is not entirely clear how enteric glial
dysfunction links to nuclear HuC/D localization, the
lack of effect observed here may well be due to
differences in how enteric glial cells are affected by
the specific toxins. Unlike the other experimental
conditions in which the GFAP labeling appeared
distorted, fluorocitrate treatment induced an increase
in GFAP expression, reminiscent of reactive gliosis.43
It has been shown that changes in the enteric glial
network, such as distortion of GFAP expression and
S100 overexpression, may occur in pathological
states.21,44,45 Experimental ablation of enteric glial
cells turned out to be devastating for enteric neurons,
causing severe motility disturbances, intestinal
inflammation and death.46,47 Earlier studies identified
GFAP as an important component of the cytoskeleton
that maintains the shape of the enteric glial cells and
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allows cell branches to mechanically and functionally
support neurons.48 Phosphorylation of the N-terminal
sites in these GFAP filaments results in disintegration
of the processes, as shown in intestinal ischemia,
which in turn can impair correct support for neu-
rons.21,44,49 We also observed the same GFAP charac-
teristics when HuC/D staining became predominantly
nuclear, which could indicate that due to GFAP
disintegration, glial cells in the gut lose their support-
ive role for neurons.
The change in subcellular localization of HuC/D
described in this study could be of great interest as a
marker of specific damage to neurons. The functional
meaning of this change in localization needs further
attention and to fully comprehend the molecular
consequences follow-up experiments are needed. One
of the proposed hypotheses is that loss of cytosolic
localization of Hu proteins contributes to mRNA
degradation in the pathophysiological condition as
the neuron goes into apoptosis, however our TUNEL
staining argues against the involvement of apoptotic
pathways. Another possibility is that the observation
of nuclear HuC/D is rather technical. A degraded
nuclear envelope could provide increased access for
antibodies to label nuclear HuC/D only in the
noxious condition. Here again, a set of experiments
using high concentrations of Triton X-100 argues
against this option. Another explanation is that
cytosolic HuC/D proteins are degraded preferentially,
while nuclear HuC/D is more protected. A last and
plausible hypothesis is that Hu proteins translocate
to the nucleus to interact with transcription and at
the same time cease their cytosolic tasks leading to
changes in translation of specific target mRNA.14,15
Indeed, we could show that the nuclear localization
of HuC/D coincides with the activation of a genetic
program as the early gene c-Fos was significantly up-
regulated.
CONCLUSION
In conclusion, our findings support the valuable
hypothesis that HuC/D is not just a pan-neuronal
marker but that its cellular localization reflects the
health status of neurons. In conditions of O2 depriva-
tion, inhibition of the mitochondrial respiratory chain,
and mechanical damage, HuC/D is predominantly
present in the nucleus. Additional studies in animal
models are warranted to understand the molecular
consequences of the change in HuC/D localization in
enteric neurons.
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